These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31138493)

  • 21. A Multi-Stakeholder Consensus-Driven Research Agenda for Better Understanding and Supporting the Emotional Impact of Harmful Events on Patients and Families.
    Bell SK; Etchegaray JM; Gaufberg E; Lowe E; Ottosen MJ; Sands KE; Lee BS; Thomas EJ; Van Niel M; Kenney L;
    Jt Comm J Qual Patient Saf; 2018 Jul; 44(7):424-435. PubMed ID: 30008355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Orphanet, an information site on rare diseases].
    Aymé S
    Soins; 2003; (672):46-7. PubMed ID: 12655825
    [No Abstract]   [Full Text] [Related]  

  • 24. China launched a pilot project to improve its rare disease healthcare levels.
    Cui Y; Zhou X; Han J
    Orphanet J Rare Dis; 2014 Jan; 9():14. PubMed ID: 24468030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confirmed versus suspected: The social significance of a genetic or non-genetic diagnosis of mitochondrial disease.
    Krieg E; Calderwood L; Campion M; Krepkovich KE
    Mitochondrion; 2016 May; 28():60-6. PubMed ID: 27017995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders.
    Angelini C; Federico A; Reichmann H; Lombes A; Chinnery P; Turnbull D
    Eur J Neurol; 2006 Sep; 13(9):923-9. PubMed ID: 16930355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report.
    Benjamin K; Vernon MK; Patrick DL; Perfetto E; Nestler-Parr S; Burke L
    Value Health; 2017; 20(7):838-855. PubMed ID: 28712612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing clinical practice guidelines: social influence strategies and practitioner behavior change.
    Mittman BS; Tonesk X; Jacobson PD
    QRB Qual Rev Bull; 1992 Dec; 18(12):413-22. PubMed ID: 1287523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An interpretation of the expert consensus on standards for the management of patients with primary mitochondrial disease from the Mitochondrial Medicine Society].
    Guo Y; Hong SQ; Jiang L
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Nov; 20(11):887-892. PubMed ID: 30477617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based medicine for consumers: a role for the Cochrane Collaboration.
    White PJ
    J Med Libr Assoc; 2002 Apr; 90(2):218-22. PubMed ID: 11999180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders.
    Tischner C; Wenz T
    Mitochondrion; 2015 Sep; 24():32-49. PubMed ID: 26134435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The actual questions of the care of rare diseases].
    Pogány G
    Orv Hetil; 2017 Nov; 158(47):1851-1856. PubMed ID: 29153019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A stakeholder visioning exercise to enhance chronic care and the integration of community pharmacy services.
    Franco-Trigo L; Tudball J; Fam D; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2019 Jan; 15(1):31-44. PubMed ID: 29496521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial disease: learning from Charlie's lesson, trying to cure, trying much more to care.
    Limongelli G; Wahbi K
    Future Cardiol; 2018 Jul; 14(4):273-276. PubMed ID: 29947560
    [No Abstract]   [Full Text] [Related]  

  • 37. How does the culture of medical group practices influence the types of programs used to assure quality of care?
    Kaissi A; Kralewski J; Curoe A; Dowd B; Silversmith J
    Health Care Manage Rev; 2004; 29(2):129-38. PubMed ID: 15192985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to harmonize mitochondrial syndrome nomenclature and classification: A consensus from the North American Mitochondrial Disease Consortium (NAMDC).
    Emmanuele V; Ganesh J; Vladutiu G; Haas R; Kerr D; Saneto RP; Cohen BH; Van Hove JLK; Scaglia F; Hoppel C; Rosales XQ; Barca E; Buchsbaum R; Thompson JL; DiMauro S; Hirano M;
    Mol Genet Metab; 2022 Jun; 136(2):125-131. PubMed ID: 35606253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and treatment of mitochondrial disorders.
    Chinnery PF; Turnbull DM
    Am J Med Genet; 2001; 106(1):94-101. PubMed ID: 11579428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of continuous quality improvement methods in the development and dissemination of medical practice guidelines.
    Burns LR; Denton M; Goldfein S; Warrick L; Morenz B; Sales B
    QRB Qual Rev Bull; 1992 Dec; 18(12):434-9. PubMed ID: 1287525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.